Lazard Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.7M | Sell |
33,119
-629
| -2% | -$207K | 0.02% | 429 |
|
|
2025
Q4 | $11.8M | Sell |
33,748
-2,473
| -7% | -$836K | 0.02% | 390 |
|
|
2025
Q3 | $11.7M | Sell |
36,221
-19,664
| -35% | -$6.12M | 0.02% | 396 |
|
|
2025
Q2 | $21.7M | Buy |
55,885
+2,983
| +6% | +$1.2M | 0.03% | 382 |
|
|
2025
Q1 | $23M | Buy |
52,902
+13,063
| +33% | +$5.24M | 0.04% | 320 |
|
|
2024
Q4 | $14.7M | Sell |
39,839
-7,120
| -15% | -$2.98M | 0.02% | 396 |
|
|
2024
Q3 | $24.4M | Sell |
46,959
-86,127
| -65% | -$46M | 0.03% | 308 |
|
|
2024
Q2 | $72.1M | Sell |
133,086
-9,671
| -7% | -$5.11M | 0.09% | 167 |
|
|
2024
Q1 | $74M | Buy |
142,757
+15,586
| +12% | +$7.75M | 0.09% | 171 |
|
|
2023
Q4 | $60M | Buy |
127,171
+1,050
| +0.8% | +$486K | 0.08% | 189 |
|
|
2023
Q3 | $54.9M | Buy |
126,121
+27,659
| +28% | +$12.5M | 0.07% | 189 |
|
|
2023
Q2 | $43.7M | Sell |
98,462
-987
| -1% | -$455K | 0.05% | 229 |
|
|
2023
Q1 | $45.7M | Sell |
99,449
-3,933
| -4% | -$1.87M | 0.06% | 242 |
|
|
2022
Q4 | $53M | Sell |
103,382
-64,983
| -39% | -$33M | 0.07% | 221 |
|
|
2022
Q3 | $76.5M | Sell |
168,365
-10,446
| -6% | -$5M | 0.11% | 167 |
|
|
2022
Q2 | $86.3M | Sell |
178,811
-6,539
| -4% | -$3.23M | 0.12% | 154 |
|
|
2022
Q1 | $91M | Sell |
185,350
-2,052
| -1% | -$938K | 0.11% | 175 |
|
|
2021
Q4 | $86.9M | Sell |
187,402
-28,808
| -13% | -$12.1M | 0.09% | 195 |
|
|
2021
Q3 | $80.6M | Sell |
216,210
-10,171
| -4% | -$3.87M | 0.09% | 206 |
|
|
2021
Q2 | $86.4M | Buy |
226,381
+16,599
| +8% | +$6.34M | 0.1% | 192 |
|
|
2021
Q1 | $75.3M | Buy |
209,782
+51,694
| +33% | +$16.6M | 0.09% | 187 |
|
|
2020
Q4 | $50.8M | Sell |
158,088
-58,111
| -27% | -$17.8M | 0.06% | 242 |
|
|
2020
Q3 | $58.1M | Buy |
216,199
+57,759
| +36% | +$15.5M | 0.08% | 194 |
|
|
2020
Q2 | $41.7M | Sell |
158,440
-514,184
| -76% | -$137M | 0.06% | 213 |
|
|
2020
Q1 | $153M | Sell |
672,624
-166,711
| -20% | -$45.4M | 0.28% | 78 |
|
|
2019
Q4 | $254M | Buy |
839,335
+202,126
| +32% | +$55.6M | 0.36% | 73 |
|
|
2019
Q3 | $153M | Sell |
637,209
-161,456
| -20% | -$44.2M | 0.25% | 93 |
|
|
2019
Q2 | $225M | Buy |
798,665
+676,257
| +552% | +$185M | 0.37% | 70 |
|
|
2019
Q1 | $35.1M | Sell |
122,408
-62,331
| -34% | -$18M | 0.06% | 222 |
|
|
2018
Q4 | $48.5M | Sell |
184,739
-15,415
| -8% | -$4.24M | 0.09% | 159 |
|
|
2018
Q3 | $54.9M | Buy |
200,154
+33,997
| +20% | +$8.83M | 0.09% | 162 |
|
|
2018
Q2 | $39.5M | Buy |
166,157
+3,609
| +2% | +$836K | 0.07% | 196 |
|
|
2018
Q1 | $35.7M | Buy |
162,548
+1,373
| +0.9% | +$323K | 0.06% | 203 |
|
|
2017
Q4 | $36.3M | Buy |
161,175
+55,706
| +53% | +$11.9M | 0.06% | 209 |
|
|
2017
Q3 | $20M | Buy |
105,469
+59,559
| +130% | +$11.3M | 0.04% | 286 |
|
|
2017
Q2 | $8.64M | Sell |
45,910
-530
| -1% | -$95.2K | 0.02% | 457 |
|
|
2017
Q1 | $7.68M | Sell |
46,440
-815
| -2% | -$130K | 0.01% | 502 |
|
|
2016
Q4 | $6.79M | Sell |
47,255
-1,450
| -3% | -$194K | 0.01% | 494 |
|
|
2016
Q3 | $6.1M | Sell |
48,705
-2,150
| -4% | -$278K | 0.01% | 490 |
|
|
2016
Q2 | $6.68M | Buy |
50,855
+50
| +0.1% | +$6.84K | 0.01% | 466 |
|
|
2016
Q1 | $7.06M | Buy |
50,805
+7,170
| +16% | +$958K | 0.02% | 446 |
|
|
2015
Q4 | $6.08M | Buy |
43,635
+11,365
| +35% | +$1.57M | 0.01% | 488 |
|
|
2015
Q3 | $4.52M | Buy |
32,270
+32,241
| +111,176% | +$4.85M | 0.01% | 498 |
|
|
2015
Q2 | $4K | Buy |
+29
| New | +$4.63K | ﹤0.01% | 1092 |
|
|
2013
Q3 | – | Sell |
-36,740
| Closed | -$3.01M | – | 974 |
|
|
2013
Q2 | $3.01M | Buy |
+36,740
| New | +$2.75M | 0.01% | 577 |
|
Other funds holding ELV
VCM
VPM
Lazard Asset Management's ELV Position: Q1 2026 in Review
Lazard Asset Management reduced its Elevance Health (ELV) stake by 1.9% in Q1 2026, selling an estimated $207K and leaving 33,119 shares worth $9.7M. The position accounts for 0.02% of the portfolio, ranked #429.
Lazard Asset Management first reported a position in ELV in Q2 2013 and has held it in 45 quarters since. The position peaked at $254M in Q4 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Lazard Asset Management held 33,119 shares of Elevance Health worth $9.7M as of Q1 2026.
- Lazard Asset Management sold 629 Elevance Health shares in Q1 2026, an estimated $207K.
- Elevance Health made up 0.02% of Lazard Asset Management's portfolio in Q1 2026, its #429 holding.
- Lazard Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 45 quarters since.
- Lazard Asset Management's Elevance Health position peaked at $254M in Q4 2019.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.